ArticleArchives of osteoporosis2025
Trends of incidence and 1-year mortality of vertebral fractures in Korea using nationwide claims data.
Article in Archives of osteoporosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cumulative Lifestyle Profiles and Osteoporotic Fracture Risk in Older Women: A Nationwide Korean Cohort Study.Healthcare (Basel, Switzerland) · 2026Article
- Trends of incidence and 1-year mortality of vertebral fractures in Korea.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Using nationwide data from 2006 to 2022, we found that vertebral fracture rates in Korea plateaued recently, with a slight decline during COVID-19, while one-year mortality remained unchanged. These findings highlight the growing burden of osteoporotic fractures and underscore the need for targeted prevention and management strategies. PURPOSE: Our purposes were to evaluate the trends in the incidence and mortality of vertebral fractures and the effects of COVID-19 between 2006 and 2022 in Korea, using nationwide data from the National Health Insurance Service (NHIS).
methodsA nationwide dataset was evaluated to identify all new visits to medical institutes for vertebral fractures in men and women aged 50 years or older between 2006 and 2022. Patients were defined using ICD-10 diagnosis codes combined with procedure codes to ensure specificity. The incidence and 1-year mortality rates were calculated. The age- and sex-standardized incidence rates were calculated using the 2020 Korean population as the reference, which demonstrated a plateauing trend in recent years.
resultsWhile the number of vertebral fractures increased, the incidence plateaued around 2010. Men and women respectively experienced 17,872 and 66,980 vertebral fractures in 2006 and 43,901 and 136,826 in 2022. The crude incidence of vertebral fractures changed from 319.4/100,000 to 408.5/100,000 person-years in men and 1011.1/100,000 to 1155.5/100,000 person-years in women between 2006 and 2022. The 1-year mortality rate after vertebral fractures gradually decreased from 6.5% in 2006 to 6.2% in 2021. There was no remarkable change of mortality during the outbreak of COVID-19. The overall mortality of vertebral fractures in men was about twice as high women as during the whole study period.
conclusionThe incidence of vertebral fractures remained relatively stable after 2010 in Korea. During the outbreak of COVID-19, incidence of vertebral fractures decreased while the mortality after vertebral fractures was unaffected.
Indexed as
Identifiers
41129043What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.